SeaStar Medical Holding Corp 8-K/A, filed Jun 23, 2026
SeaStar Medical Holding Corp (ICU)
8-K/A
2026-06-23
For: 2025-08-13
View Original
Added on
June 23, 2026
About this 8-K/A
SeaStar Medical Holding Corp filed this 8-K/A on June 23, 2026, reporting on events of August 13, 2025.
Items reported
- Item 5.02: Director or officer change, or executive pay
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date of Report (Date of earliest event reported):
|
(Exact name of Registrant as Specified in Its Charter)
|
|
|
|
|
(State or Other Jurisdiction
of Incorporation) |
(Commission File Number)
|
(IRS Employer
Identification No.) |
|
|
||
|
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
|
Registrant’s Telephone Number, Including Area Code:
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading
Symbol(s) |
Name of each exchange on which registered
|
||
|
|
|
The
|
||
|
|
|
The
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 5.02
|
Departure of Directors or Certain Officer; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On June 10, 2026, SeaStar Medical Holding Corporation (the "Company") and Mr. Green entered into a separation and release agreement releasing all claims surrounding the disputed not-for-cause termination referenced in the 8-K signed on August 19, 2025, with a mutual resolution, pursuant to which SeaStar has agreed to pay Mr. Green more than what was previously disclosed in the 8-K signed on August 19, 2025.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
SeaStar Medical Holding Corporation
|
|
By:
|
/s/ Eric Schlorff
|
||
|
Date:
|
June 23, 2026
|
Name:
|
Eric Schlorff
|
|
Title:
|
Chief Executive Officer
|